HR 9879 · 118th Congress 2023โ€“2025, ended

SIMSA Act of 2024

Latest action · Sep 27, 2024 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedSep 27, 2024
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Cosponsors 3

Members who signed on, in the order they did. All signed on Sep 27, 2024.

SeatCosponsorSigned on
D-NCDonald G. DavisOriginalSep 27, 2024
D-CAJimmy PanettaOriginalSep 27, 2024
R-SCRussell FryOriginalSep 27, 2024

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Sep 27, 2024
HouseJudiciary Committee
Referred Sep 27, 2024

Actions 2

Everything that happened, newest first.

  1. Sep 27, 2024Introduced in House
  2. Sep 27, 2024Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I Section 8 of the United States Constitution The single subject of this legislation is: To provide the Drug Enforcement Administration (DEA) with the authority to temporarily and permanently schedule synthetic analogues of controlled substances as Schedule A drugs, in order to prevent their unlawful importation, manufacture, and abuse.

The sponsor’s statement, as printed in the Congressional Record, vol. 170, no. 151, September 27, 2024, page H5839.

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Controlled Substances Act to clarify how controlled substance analogues that are imported or offered for import are to be regulated, and for other purposes.
Short Title(s) as Introduced
SIMSA Act of 2024
Stop the Importation and Manufacturing of Synthetic Analogues Act of 2024

Subjects

Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.

Text 1

Each version as it was printed, newest first.

  1. Sep 27, 2024Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.